RxDoctor Payments Data

Faheem Shaikh, MD

Hospitalist · Birmingham, ALNPI 1609038561

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,831 of the $3,429 with a category attached, or 82.6%. 3 manufacturers reported payments, led by AstraZeneca at 52.5% of the total. Among hospitalist clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,429in general payments, 2019–2025

Across 19 payments — averaging $180.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Modernatx, Inc.$2K
  • Johnson & Johnson$37
$1,835,992in research payments, 2019–2025

Across 251 payments — averaging $7314.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$983K
  • Sanofi Pasteur Inc.$428K
  • Seqirus USA Inc$225K
  • AstraZeneca$120K
  • Pfizer$43K
  • Genentech, Inc.$23K
  • plus $14K from 1 others

What the payments were for

  • Travel & lodging$2,83183%
  • Food & beverage$59817%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca10$1,800
Modernatx, Inc.8$1,591
Johnson & Johnson1$37

How this compares

$3,429 in reported general payments places this provider in the 95th percentile of 265 hospitalist providers in Alabama.

See all hospitalist providers in Alabama

Medicare billing

Part B allowed, 2024
$29,866
Medicare patients
75
Services billed
342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →